FIELD: pharmacology.
SUBSTANCE: invention relates to a pharmaceutical antidiabetic composition based on (+)-cis-3-(1H-benzimidazol-2-yl)-1,2,2-trimethylcyclopentane carboxylic acid, characterized in that it comprises microcrystalline cellulose 102, Povidone K30, croscarmellose sodium, magnesium stearate and talc as pharmaceutically acceptable excipients.
EFFECT: increased bioavailability of the formulation active agent.
2 cl, 3 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
(±)-CIS-3-(2'-BENZIMIDAZOLYL)-1,2,2-TRIMETHYLCYCLO- PENTANE CARBOXYLIC ACID ELICITING SUGAR-REDUCING AND ANTIDIABETOGENIC EFFECT | 2000 |
|
RU2205826C2 |
PHARMACEUTICAL COMPOSITION, MEDICATION FOR PREVENTION AND TREATMENT OF METABOLIC SYNDROME AND DIABETIC NEPHROPATHY AND METHOD OF OBTAINING THEREOF | 2011 |
|
RU2519744C2 |
COMBINATION FOR TREATMENT OF DIABETES AND COMPLICATIONS THEREOF | 2011 |
|
RU2451506C1 |
PHARMACEUTICAL ACTIVE INGREDIENT AND ITS APPLICATION, IN PARTICULAR FOR PREVENTION AND TREATMENT OF METABOLIC DISORDERS IN HUMANS AND ANIMALS | 2018 |
|
RU2759903C2 |
COMBINATIONS AND COMPOSITIONS CONTAINING FATTY ACIDS AND AMINO ACIDS, THEIR APPLICATION FOR PREVENTION AND DELAY OF PROGRESSING OR TREATMENT OF DIABETES AND DIABETES ASSOCIATED DISEASES AND CONDITIONS, METHOD OF WEIGHT REDUCTION IN MAMMAL, KIT | 2004 |
|
RU2356247C2 |
APPLICATION OF PIRASOLE DERIVATIVE FOR OBTAINMENT OF MEDICINE FOR PREVENTION AND TREATMENT OF DYSLIPIDEMIA AND DISEASES RELATED TO DYSLIPIDEMIA AND/OR OBESITY | 2004 |
|
RU2357731C2 |
METHOD FOR TREATING METABOLISM DISORDERS MAINLY DIABETES CASES AND DISEASES OR STATES RELATED TO DIABETES | 2000 |
|
RU2280447C2 |
COMBINED DELIVERY SYSTEM WITH IMMEDIATE/SUSTAINED RELEASE OF MEDICINAL AGENTS WITH SHORT PERIOD OF HALF-LIFE, INCLUDING FOR REMOGLIFLOZIN | 2011 |
|
RU2596787C2 |
PHARMACEUTICAL COMPOSITION BASED ON 5-PENTYLRESORCINOL WITH HYPOGLYCEMIC EFFECT AND BODY WEIGHT REDUCTION EFFECT | 2023 |
|
RU2829635C1 |
DERIVATIVES OF BIGUANIDE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2276136C2 |
Authors
Dates
2017-07-07—Published
2016-05-16—Filed